Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Merck and Bristol-Myers Squibb sign distribution agreement
Under the terms of this agreement, Merck Serono acquires the exclusive rights to market, sell and distribute more than 30 prescription medicines, in particular in the CardioMetabolic Care
Under the terms of this agreement, Merck Serono acquires the exclusive rights to market, sell and distribute more than 30 prescription medicines, in particular in the CardioMetabolic Care
The research involved 42 men diagnosed with erectile dysfunction and various other conditions such as high blood pressure, high cholesterol, diabetes and removal of the prostate. The average
Under the terms of the agreement, QLT will receive a one-time cash payment of approximately $150 million upon closing, which is expected to occur in the third quarter
The primary purpose of this prospective, randomized multicenter study is to evaluate and compare the outcomes of high risk colorectal or coloanal anastomoses constructed with Gore Seamguard Bioabsorbable
The trial demonstrated statistical significance for its primary efficacy endpoint, which was the change in FEV1 (Forced Expiratory Volume in One Second) from baseline at the trial endpoint
In the merger, each share of Encysive’s outstanding common stock was cancelled and (except for shares held by Encysive, Pfizer or by their wholly-owned subsidiaries or by holders
Vacci-Test Tetanus is a rapid, sensitive, lateral flow diagnostic test to determine the immune status of an individual by detecting the presence of circulating antibodies. This time saving,
Under the terms of the alliance, Nuevolution’s proprietary Chemetics drug discovery technology will be applied to identify novel small molecule lead compounds against a range of drug targets
Radius selected RAD140 from a series of promising selective androgen receptor modulators (SARM) after it demonstrated exceptional selectivity for anabolic activity in well-validated in vivo models. Radius expects
The company believes that it is the first to file an abbreviated new drug application (ANDA) with a Paragraph IV certification against Vanos. Perrigo filed its ANDA for